Raymond James & Associates Lowers Position in VanEck Biotech ETF (NASDAQ:BBH)
Raymond James & Associates lessened its holdings in VanEck Biotech ETF (NASDAQ:BBH – Free Report) by 1.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,233 shares of the company’s stock after selling 97 shares during the period. Raymond James & Associates owned 0.25% of VanEck […]
More Stories
Clean Power Hydrogen (LON:CPH2) Hits New 12-Month Low – What’s Next?
Clean Power Hydrogen Plc (LON:CPH2 – Get Free Report)’s share price reached a new 52-week low on Tuesday . The...
PagerDuty (NYSE:PD) Issues Q4 Earnings Guidance
PagerDuty (NYSE:PD – Get Free Report) updated its fourth quarter earnings guidance on Tuesday. The company provided earnings per share...
Workday (NASDAQ:WDAY) Announces Earnings Results
Workday (NASDAQ:WDAY – Get Free Report) released its earnings results on Tuesday. The software maker reported $1.89 earnings per share...
Critical Survey: Pinterest (NYSE:PINS) vs. PubMatic (NASDAQ:PUBM)
PubMatic (NASDAQ:PUBM – Get Free Report) and Pinterest (NYSE:PINS – Get Free Report) are both computer and technology companies, but...
Insider Selling: Atlassian Co. (NASDAQ:TEAM) Director Sells 7,948 Shares of Stock
Atlassian Co. (NASDAQ:TEAM – Get Free Report) Director Scott Farquhar sold 7,948 shares of the firm’s stock in a transaction...
AAON, Inc. (NASDAQ:AAON) VP Stephen E. Wakefield Sells 5,750 Shares
AAON, Inc. (NASDAQ:AAON – Get Free Report) VP Stephen E. Wakefield sold 5,750 shares of the business’s stock in a...